For the quarter ending 2026-03-31, ABT made $11,164M in revenue. $1,077M in net income. Net profit margin of 9.65%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 11,164 | 11,459 | 11,369 | 11,142 |
| Cost of products sold, excluding amortization of intangible assets | 4,890 | 4,922 | 5,075 | 4,854 |
| Amortization of intangible assets | 422 | 422 | 420 | 420 |
| Research and development | 767 | 735 | 766 | 725 |
| Selling, general, and administrative | 3,740 | 3,129 | 3,051 | 3,091 |
| Total operating cost and expenses | 9,819 | 9,208 | 9,312 | 9,090 |
| Operating earnings | 1,345 | 2,251 | 2,057 | 2,052 |
| Interest expense | 174 | 120 | 121 | 121 |
| Interest (income) | 106 | 78 | 77 | 71 |
| Net foreign exchange (gain) loss | 13 | 15 | 17 | 11 |
| Other (income) expense, net | 159 | 134 | 150 | 137 |
| Earnings before taxes | 1,449 | 2,358 | 2,180 | 2,150 |
| Taxes on earnings | 372 | 582 | 536 | 371 |
| Net earnings | 1,077 | 1,776 | 1,644 | 1,779 |
| Basic EPS | 0.62 | 1.021 | 0.94 | 1.02 |
| Diluted EPS | 0.61 | 1.018 | 0.94 | 1.01 |
| Basic Average Shares | 1,742,480,000 | 1,739,215,000 | 1,742,142,000 | 1,743,437,000 |
| Diluted Average Shares | 1,747,073,000 | 1,744,584,000 | 1,749,361,000 | 1,750,835,000 |
ABBOTT LABORATORIES (ABT)
ABBOTT LABORATORIES (ABT)